David Sans - Chief of Corporate Development at Calidi Biotherapeutics, Inc.

Insider Transactions and Holdings

Identity 2 facts
Entity type
Individual
Role
Chief of Corporate Development
Issuer context 1 fact
Issuer symbol
CLDI on NYSE, CLDWW on OTC
SEC evidence 1 fact
Source evidence
Open source filing history

There are no Buy or Sell transactions made by David Sans since 01 Jun 2025

Holdings reported by David Sans for Calidi Biotherapeutics, Inc.

Form 4 holding Chief of Corporate Development

Calidi Biotherapeutics, Inc.

Security class
Common Stock
Shares / value
18,314
Estimated value
$32,965
Report date
12 Sep 2023
Price
$1.80
Ownership
Direct

Transactions reported by David Sans for Calidi Biotherapeutics, Inc.

Sym Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .